HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (V114) SEROTYPES IN CHILDREN IN HONG KONG

被引：0
|
作者：
Mohanty, S. [1 ]
Sukarom, I [2 ]
Cheng, S. S. Y. [3 ]
Owusu-Edusei, K. [1 ]
Hu, T. [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] MSD Asia Pacific, Bangkok, Thailand
[3] MSD Asia Ltd, Hong Kong, Peoples R China
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN67
引用
收藏
页码：S555 / S555
页数：1
相关论文
共 50 条
  • [1] HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (V114) SEROTYPES IN CHILDREN IN SOUTH KOREA
    Mohanty, S.
    Sukarom, I
    Yang, G.
    Park, J.
    Owusu-Edusei, K.
    Hu, T.
    [J]. VALUE IN HEALTH, 2020, 23 : S550 - S550
  • [2] Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong
    Mohanty, Salini
    Hu, Tianyan
    Yang, GyongSeon
    Khan, Tsz K.
    Owusu-Edusei, Kwame
    Sukarom, Isaya
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [3] Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States
    Hu, Tianyan
    Weiss, Thomas
    Owusu-Edusei, Kwame
    Petigara, Tanaz
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (12) : 1653 - 1660
  • [4] HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE SEROTYPES IN CHILDREN IN THREE EUROPEAN COUNTRIES
    Hu, T.
    Bencina, G.
    Petigara, T.
    Elbasha, E.
    [J]. VALUE IN HEALTH, 2019, 22 : S646 - S646
  • [5] HEALTH AND ECONOMIC BURDEN ASSOCIATED WITH 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV15) SEROTYPES IN CHILDREN IN THE UNITED STATES
    Hu, T.
    Petigara, T.
    Elbasha, E.
    [J]. VALUE IN HEALTH, 2019, 22 : S201 - S201
  • [6] Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV
    Mohapi, Lerato
    Pinedo, Yvett
    Osiyemi, Olayemi
    Supparatpinyo, Khuanchai
    Ratanasuwan, Winai
    Molina, Jean-Michel
    Dagan, Ron
    Tamms, Gretchen
    Sterling, Tina
    Zhang, Ying
    Pedley, Alison
    Hartzel, Jon
    Kan, Yanqing
    Hurtado, Kim
    Musey, Luwy
    Simon, Jakub K.
    Buchwald, Ulrike K.
    [J]. AIDS, 2022, 36 (03) : 373 - 382
  • [7] Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
    Kwame Owusu-Edusei
    Arijita Deb
    Kelly D. Johnson
    [J]. Infectious Diseases and Therapy, 2022, 11 : 987 - 999
  • [8] Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countries
    Hu, Tianyan
    Weiss, Thomas
    Bencina, Goran
    Owusu-Edusei, Kwame
    Petigara, Tanaz
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1098 - 1107
  • [9] A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
    Wilck, Marissa
    Barnabas, Shaun
    Chokephaibulkit, Kulkanya
    Violari, Avy
    Kosalaraksa, Pope
    Yesypenko, Svitlana
    Chukhalova, Iryna
    Dagan, Ron
    Richmond, Peter
    Mikviman, Elena
    Morgan, Leslie
    Feemster, Kristen
    Lupinacci, Robert
    Chiarappa, Joseph A.
    Madhi, Shabir
    Bickham, Kara
    Musey, Luwy
    [J]. AIDS, 2023, 37 (08) : 1227 - 1237
  • [10] Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study
    Quinn, Charles T.
    Wiedmann, Richard T.
    Jarovsky, Daniel
    Lopez-Medina, Eduardo
    Rodriguez, Hilze M.
    Papa, Melanie
    Boggio, Gordana
    Shou, Qiong
    Dagan, Ron
    Richmond, Peter
    Feemster, Kristen
    McFetridge, Richard
    Tamms, Gretchen
    Lupinacci, Robert
    Musey, Luwy
    Bickham, Kara
    [J]. BLOOD ADVANCES, 2023, 7 (03) : 414 - 421
12345